Ptt 大爆卦 | FDA Meeting - 前往 https://www.dermatologytimes.com/view/dupilumab-fda-approved-for-ad-patients-6-months-to-5-years

你即將離開本站

並前往https://www.dermatologytimes.com/view/dupilumab-fda-approved-for-ad-patients-6-months-to-5-years

Dupilumab FDA Approved for AD Patients 6 months to 5 years

Sanofi and Regeneron Pharmaceuticals, Inc announced the FDA approval of dupilumab. It is now the first biologic medicine for children from 6 ...

確定！回上一頁

查詢「FDA Meeting」的人也找了：